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A complete understanding of pancreatic islet biology is essential to the development of 
preventive or curative interventions for diabetes.  It has been known that subpopulations 
of islets of different sizes exist; however, whether they are biologically and functionally 
unique has not been investigated.  As an example, our work comparing the biology of 
large versus small islets isolated from rats showed that small islets were superior to 
large islets in in vitro function and in transplantation outcomes.  These results provided 
the stimulus for an improved approach to islet transplantation in humans.  The work also 
led to new questions regarding the basic physiology of healthy islets.  Through 
collaboration between our University of Kansas Medical Center and Children’s Mercy 
Hospital teams, we determined that small islets secrete higher amount of insulin in vitro 
when compared to the large islets.  We sought to identify whether the islet 
subpopulations showed differences at the molecular level and thus we investigated their 
protein expression profiles using two-dimensional polyacrylamide gel electrophoresis 
(2D PAGE).  We found that the protein repertoire in the small and large islets differed 
significantly.  Specifically, some proteins were found only in one type of islets, small or 
large, while they were missing or their expression levels were different in the other 
subpopulation.  We identified some of the proteins by liquid chromatography – mass 
spectrometry.  Immunofluorescence performed on small and large islets in pancreatic 
sections, with antibodies against identified proteins, confirmed that the proteins were 
present in one subpopulation of islets.  Of these proteins, at least one was unique to 
large islets and can potentially be used as a marker to distinguish in vivo between islets 
that are high-insulin producers and those that fail to secrete significant amounts in 
insulin.  Our long-term goal is to monitor the fate of the different islet populations during 
diabetes development.  In addition, markers like this can be used to determine the best 
islet subpopulation for transplantation.  The data support our hypothesis that integral 
differences exist between small and large islets that might determine the islets’ unique 
properties under normal conditions and during the development of diabetes.  These 
differences may also influence islet subpopulation behavior in transplantation affecting 
the outcome. 
 
